ArriVent BioPharma, Inc. (AVBP) Misses Q1 EPS by 12c
Tweet
Share
E-mailGet Alerts AVBP Hot Sheet
Join SI Premium – FREE
ArriVent BioPharma, Inc. (NASDAQ: AVBP) reported Q1 EPS of ($0.96), $0.12 worse than the analyst estimate of ($0.84).
For earnings history and earnings-related data on ArriVent BioPharma, Inc. (AVBP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lumentum (LITE) PT Raised to $1,000 at Morgan Stanley
- JPMorgan Upgrades Grupo Aval (AVAL) to Neutral
- Canterbury Park (CPHC) Misses Q2 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
